4//SEC Filing
Insys Therapeutics, Inc. 4
Accession 0001209191-15-028226
CIK 0001516479operating
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:43 PM ET
Size
6.9 KB
Accession
0001209191-15-028226
Insider Transaction Report
Form 4
Babich Michael L
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2015-03-20−5,000→ 38,034 totalExercise: $3.25Exp: 2021-03-27→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2015-03-20$3.25/sh+5,000$16,250→ 207,752 total
Footnotes (1)
- [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on March 28, 2015.
Documents
Issuer
Insys Therapeutics, Inc.
CIK 0001516479
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001516479
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 4:43 PM ET
- Size
- 6.9 KB